STOCK TITAN
  1. Home
  2. News
  3. RDHL

Redhill Biopharma Ltd. - RDHL STOCK NEWS

IMPACT
SENTIMENT
RDHL : Nasdaq REDIF : OTC
RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares
offering
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Pricing of $15.5 Million Public Offering of American Depositary Shares
offering
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Underwritten Public Offering of American Depositary Shares
offering
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Ltd Announces RedHill: LPI in Part A of RHB-107 P2/3 COVID Study
covid-19
IMPACT
SENTIMENT
RDHL : Nasdaq REDIF : OTC
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients
clinical trial covid-19
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma to Present at H.C. Wainwright 7th Annual Israel Conference and German Equity Forum (EKF) 2021
conferences
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Presents New Talicia(R) and Movantik(R) Data Analyses at ACG 2021
IMPACT
SENTIMENT
RDHL : Nasdaq REDIF : OTC
RedHill Biopharma Presents New Talicia® and Movantik® Data Analyses at ACG 2021
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma to Present at the BIO-Europe 2021 Conference
conferences
Stock RDHL logo
Redhill Biopharma Ltd.

Nasdaq:RDHL

RDHL Rankings

#6694 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RDHL Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Israel
21 Haarbaa St

About RDHL

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise